Plethico Pharmaceuticals (PLETHICO) is a pharmaceutical company engaged in manufacturing and marketing generic formulations and consumables. It was established in 1985 and was converted into a public limited company in 1993. The company`s product profile includes herbal healthcare products to treat life style-related disorders like diabetes, cholesterol, sleep disorders, digestive disorders and pain management; consumer healthcare products and neutraceuticals in the sports nutrition, pharma OTC, confectionary, herbal supplements, foot care, cough and cold category, digestive care, and oral hygiene; over 400 different pharmaceutical formulations in more than 39 therapeutic segments with presence in anti-malarials, anti-tubercular, anti-infectives, pain, cough and cold, cardiac, and gastro categories; and a range of hospital consumables, disposables, sutures, diagnostic kits, and veterinary products. Recent launches include Dr Relief and Coolz. The company has two fully integrated WHO-GMP certified manufacturing units in Madhya Pradesh. The R&D division focuses on the areas of NDDS (novel drug delivery system); analytical, pharmaceutical, and clinical research; and international regulatory affairs. The company offers contract manufacturing services with over 40 years of experience from the pilot to the commercial scale. The company has a major presence in India with a vibrant supply-chain network. It has more than 400 product approvals, operations in more than 25 countries, and exports to over 45 countries with a dominant presence in regions like the CIS, Africa, Latin America and South East Asia. The company has raised USD 75 million via FCCBs to gain a foothold in the US markets. The registered office is located at AB Road, Manglia, Indore-453771, Madhya Pradesh.
Plethico Pharmaceuticals Live Stock Price, Share Chart, Quotes, NSE, BSE
Plethico Pharmaceuticals (PLETHICO) is a pharmaceutical company engaged in manufacturing and marketing generic formulations and consumables. It was established in 1985 and was converted into a public limited company in 1993. The company`s product profile includes herbal healthcare products to treat life style-related disorders like diabetes, cholesterol, sleep disorders, digestive disorders and pain management; consumer healthcare products and neutraceuticals in the sports nutrition, pharma OTC, confectionary, herbal supplements, foot care, cough and cold category, digestive care, and oral hygiene; over 400 different pharmaceutical formulations in more than 39 therapeutic segments with presence in anti-malarials, anti-tubercular, anti-infectives, pain, cough and cold, cardiac, and gastro categories; and a range of hospital consumables, disposables, sutures, diagnostic kits, and veterinary products. Recent launches include Dr Relief and Coolz. The company has two fully integrated WHO-GMP certified manufacturing units in Madhya Pradesh. The R&D division focuses on the areas of NDDS (novel drug delivery system); analytical, pharmaceutical, and clinical research; and international regulatory affairs. The company offers contract manufacturing services with over 40 years of experience from the pilot to the commercial scale. The company has a major presence in India with a vibrant supply-chain network. It has more than 400 product approvals, operations in more than 25 countries, and exports to over 45 countries with a dominant presence in regions like the CIS, Africa, Latin America and South East Asia. The company has raised USD 75 million via FCCBs to gain a foothold in the US markets. The registered office is located at AB Road, Manglia, Indore-453771, Madhya Pradesh.
